Profile data is unavailable for this security.
About the company
Hunan FangshengPharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of cardiovascular medicine, orthopedic medicine, pediatric medicine, gynecological medicine and anti-infective medicine. The Company's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The Company distributes its products primarily in domestic market.
- Revenue in CNY (TTM)1.65bn
- Net income in CNY168.39m
- Incorporated1997
- Employees1.60k
- LocationHunan Fangsheng Pharmaceutical Co LtdNo.19 Lutian Road, Lugu, HexiCHANGSHA 410205ChinaCHN
- Phone+86 73 188997135
- Fax+86 73 188908647
- Websitehttp://www.fangsheng.com.cn
More ▼
Mergers & acquisitions
| Acquired company | 603998:SHH since announced | Transaction value |
|---|---|---|
| Hunan Fangsheng Ruixin Pharmaceutical Co Ltd | 12.03% | 2.26m |
Data delayed at least 15 minutes, as of Mar 13 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Konruns Pharmaceutical Co Ltd | 998.77m | 146.45m | 4.70bn | 449.00 | 31.62 | 1.48 | -- | 4.74 | 0.9359 | 0.9359 | 6.38 | 20.02 | 0.2803 | 2.95 | 3.93 | 2,224,437.00 | 4.83 | 6.36 | 5.55 | 7.27 | 87.98 | 91.27 | 17.24 | 21.97 | 4.89 | 15.47 | 0.0397 | 22.35 | 7.03 | 7.97 | -31.42 | -26.68 | 23.35 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.43bn | 117.53m | 4.74bn | 584.00 | 40.08 | 2.67 | -- | 3.38 | 0.7061 | 0.7061 | 8.61 | 10.60 | 0.6264 | 1.66 | 4.42 | 2,451,945.00 | 6.11 | 5.31 | 7.69 | 6.76 | 82.35 | 86.02 | 9.76 | 8.10 | 3.25 | -- | 0.0809 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 845.14m | 230.48m | 4.75bn | 1.02k | 21.40 | 2.72 | -- | 5.91 | 1.23 | 1.23 | 4.52 | 9.72 | 0.4223 | 3.00 | 5.22 | 831,826.60 | 11.50 | 10.33 | 12.71 | 11.26 | 87.58 | 88.06 | 27.23 | 22.05 | 5.80 | -- | 0.0002 | 36.85 | 28.46 | 7.68 | 34.61 | 14.81 | 73.20 | -- |
| GemPharmatech Co Ltd | 584.83m | 154.23m | 4.87bn | 1.34k | 32.17 | 2.38 | -- | 8.48 | 0.3762 | 0.3762 | 1.43 | 5.08 | 0.2501 | 3.78 | 2.48 | 435,790.40 | 6.60 | -- | 7.40 | -- | 68.05 | -- | 26.37 | -- | 5.12 | -- | 0.0553 | -- | 31.17 | -- | 31.79 | -- | -- | -- |
| HitGen Inc | 357.22m | 33.12m | 4.91bn | 508.00 | 151.73 | 3.77 | -- | 14.13 | 0.083 | 0.083 | 0.895 | 3.34 | 0.2119 | 6.88 | 3.38 | 703,184.90 | 1.98 | 5.87 | 2.11 | 6.59 | 48.36 | 64.41 | 9.34 | 24.48 | 16.24 | -- | 0.1511 | 12.60 | 5.98 | 44.01 | -60.14 | -- | 47.85 | -- |
| Shanghai Haixin Group Co Ltd | 1.18bn | 166.03m | 4.95bn | 760.00 | 40.21 | 1.68 | -- | 4.26 | 0.1375 | 0.1375 | 0.9797 | 3.28 | 0.2403 | 7.43 | 8.13 | 1,556,014.00 | 3.90 | 2.68 | 4.42 | 3.06 | 45.07 | 44.55 | 16.24 | 11.17 | 2.75 | -- | 0.0209 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.65bn | 168.39m | 5.05bn | 1.60k | 29.60 | 3.55 | -- | 3.07 | 0.3892 | 0.3892 | 3.80 | 3.24 | 0.579 | 1.65 | 7.07 | 1,030,799.00 | 6.19 | 5.21 | 10.33 | 8.79 | 66.97 | 67.73 | 10.69 | 8.24 | 0.6734 | 23.21 | 0.3456 | 42.58 | 14.36 | 19.98 | 308.12 | 36.79 | 5.21 | 103.62 |
| Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 5.08bn | 404.00 | 18.57 | 2.49 | -- | 7.91 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 784.35m | 254.48m | 5.10bn | 1.05k | 12.49 | 2.28 | -- | 6.49 | 2.02 | 2.02 | 4.01 | 11.04 | 0.2601 | 0.9453 | 7.66 | -- | 8.44 | 10.04 | 10.25 | 11.63 | 81.59 | 83.62 | 32.44 | 28.29 | 2.82 | -- | 0.2563 | -- | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | -- |
| Sichuan Huiyu Pharmaceutical Co Ltd | 932.29m | 102.57m | 5.31bn | 1.67k | 52.70 | 1.46 | -- | 5.80 | 0.2421 | 0.2421 | 2.20 | 8.75 | 0.211 | 0.8407 | 26.50 | 558,590.60 | 2.32 | -- | 2.74 | -- | 85.48 | -- | 10.98 | -- | 3.44 | -- | 0.0949 | -- | -18.12 | -- | -44.15 | -- | -- | -- |
| Shanghai Hile Bio-Technology Co Ltd | 222.19m | 150.81m | 5.32bn | 491.00 | 35.40 | 4.55 | -- | 24.25 | 0.2313 | 0.2313 | 0.3395 | 1.80 | 0.1252 | 1.03 | 1.69 | 452,535.50 | 7.61 | 0.9734 | 9.69 | 1.43 | 47.65 | 51.66 | 60.74 | 5.84 | 1.33 | -- | 0.0295 | 22.73 | -13.62 | -0.2421 | 125.80 | 1.35 | -25.43 | 0.6107 |
| Shandong Lukang Pharmaceutical Co Ltd | 6.28bn | 267.79m | 5.40bn | 6.48k | 20.82 | 1.48 | -- | 0.8681 | 0.292 | 0.292 | 6.88 | 4.11 | 0.7187 | 3.54 | 6.45 | 967,865.70 | 3.21 | 2.21 | 5.51 | 4.05 | 23.55 | 23.41 | 4.47 | 3.46 | 0.7313 | 5.39 | 0.4689 | 31.79 | 9.34 | 13.04 | 78.37 | 8.81 | -16.95 | 23.94 |
Data as of Mar 13 2024. Currency figures normalised to Hunan Fangsheng Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
22.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 18.74m | 4.41% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2023 | 17.04m | 4.01% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 15.75m | 3.70% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 14.14m | 3.32% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 10.91m | 2.57% |
| Hotland Innovation Asset Management Co. Ltd.as of 30 Jun 2023 | 5.55m | 1.30% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 4.70m | 1.10% |
| CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 2023 | 3.39m | 0.80% |
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2023 | 3.23m | 0.76% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2023 | 3.02m | 0.71% |
More ▼
Data from 30 Jun 2023 - 23 Oct 2023Source: FactSet Research Systems Inc.
